Daiichi Sankyo Announces Clinical Research Collaboration To Evaluate Ds-1062 In Combination With Keytrudaa

Daiichi Sankyo Announces Clinical Research Collaboration To Evaluate Ds-1062 In Combination With Keytrudaa

By, Admin 1 June 2020

Daiichi Sankyo Company, Limited Announced That It Has Entered Into A Clinical Trial Collaboration Agreement With A Subsidiary Of Merck &Amp; Co., Inc., Kenilworth, New Jersey, U.S.A., Known As Msd Outside The United States And Canada, To Evaluate The Combination Of Ds-1062, A Trop2 Directed Dxd Antibody Drug Conjugate (Adc), And Keytruda&Reg; (Pembrolizumab) In Patients With Previously-Treated Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc) Without Actionable Genomic Alterations.There Are No Trop2 Directed Therapies And No Adcs Currently Approved For Treatment Of Nsclc, Which Frequently Overexpresses The Trop2 Protein.1&Ldquo;Strategic Research Collaborations Like This Support Our Goal Of Developing Our Trop2 Directed Dxd Adc In Combination With Immune Checkpoint Inhibitors To Improve Upon The Current Standard Of Care Therapies Across A Wide Range Of Nsclc Subtypes,&Rdquo; Said Gilles Gallant, Bpharm, Phd, Fopq, Senior Vice President, Global Head, Oncology Development, Oncology R&Amp;D, Daiichi Sankyo. &Ldquo;We Look Forward To Evaluating The Safety And Efficacy Of Ds-1062 In Combination With Keytruda As A Potential Combination Therapy Strategy To Advance Treatment Outcomes For Patients With Metastatic Nsclc Without Mutations Known To Drive Cancer Growth.&Rdquo;

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!